Press Releases Waters Corporation

Stocks

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - NYSE Other stock markets 01:30:02 13/06/2026 am IST			5-day change	1st Jan Change
355.53 ^USD	-1.17%		-2.69%	-6.40%

11/06	Piper Sandler Initiates Waters at Neutral With $400 Price Target	MT
08/06	Waters Corporation Launches BioResolve Peptide and GTxResolve Lipid Phenyl-Hexyl+ and C18+ Columns	CI

Press Releases

09/06	Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis	PR
09/06	Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis	AQ
08/06	Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis	PR
08/06	Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis	AQ
03/06	Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics	PR
03/06	Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics	AQ
01/06	Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research	PR
01/06	Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics	PR
01/06	Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics	AQ
01/06	Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research	AQ
19/05	Waters Corporation to Present at the Jefferies Global Healthcare Conference	PR
12/05	D. Mass. Patent Litigation Update: March 2026	AQ
05/05	Waters: Q1 Earnings Snapshot	AQ
05/05	Waters : First Quarter 2026 Non-GAAP Addendum	PU
05/05	Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results	PR
21/04	Waters Corporation Schedules First Quarter 2026 Earnings Conference Call	PR
14/04	Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules	PR
08/04	Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay	PR
18/03	Waters Prices Offering of Senior Notes	PR
09/03	Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed	PR
24/02	Waters Corporation to Present at the TD Cowen Health Care Conference	PR
17/02	Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage	PR
10/02	Waters : About Waters Infographic	PU
09/02	Waters : 沃特世完成与碧迪医疗生物科学与诊断解决方案业务的合并	PU
09/02	BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation	PR